These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28367635)

  • 21. Long-term continuous subcutaneous insulin infusion (CSII) and cardiovascular complications: Higher fractional use is not biased by risk factors.
    Tubili C; Nardone MR; Pollakova D; Di Folco U
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3306. PubMed ID: 32129928
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia.
    Janez A
    J Int Med Res; 2012; 40(4):1546-51. PubMed ID: 22971507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
    Pfützner A; Sachsenheimer D; Grenningloh M; Heschel M; Walther-Johannesen L; Gharabli R; Klonoff D
    J Diabetes Sci Technol; 2015 Sep; 9(6):1292-8. PubMed ID: 26341262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 26. Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia.
    Petrovski G; Zivkovic M; Stratrova SS; Todorova BJ
    Diabetes Technol Ther; 2017 Dec; 19(12):739-743. PubMed ID: 28976785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model.
    Zöllner YF; Ziegler R; Stüve M; Krumreich J; Schauf M
    J Diabetes Sci Technol; 2016 Sep; 10(5):1142-8. PubMed ID: 26902790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S22-8. PubMed ID: 26836426
    [No Abstract]   [Full Text] [Related]  

  • 29. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes.
    Reznik Y; Cohen O
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S219-25. PubMed ID: 23882049
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
    Maiorino MI; Petrizzo M; Bellastella G; Esposito K
    Endocrine; 2018 Jan; 59(1):62-65. PubMed ID: 28551774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 36. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
    Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
    J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
    Casas-Oñate ML; Montoya-Martínez D
    Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous subcutaneous insulin infusion in children less than 6 years-old: long-term progress].
    Colino E; Martín Frías M; Roldán B; Álvarez MÁ; Yelmo R; Barrio R
    An Pediatr (Barc); 2017 Nov; 87(5):276-283. PubMed ID: 28233713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?
    Currie CJ
    Diabet Med; 2007 Oct; 24(10):1058-9. PubMed ID: 17888127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.